Search SITE

When Minnesota legalized adult-use cannabis in August 2023 , it marked a major shift for the state and a new chapter for cannabis reform in the Midwest. Lawmakers passed a bold framework, and expectations were high that dispensaries would soon follow. Now, nearly two years later, most Minnesotans are still waiting for the first nontribal recreational dispensary to open. Albert Lea has emerged as the likely home of the state’s inaugural licensed cannabis retailer. Still, as of mid-2025, the store remains unopened, held up by licensing logistics and a sluggish rollout process. The anticipation is real, but so is the frustration. While the promise of recreational cannabis has been made, the path to access remains unclear. And for many in Minnesota, the question is not just when stores will open, but why they are still waiting at all. A Law Passed, But Retail Still on Pause Minnesota's adult-use cannabis law was signed in the summer of 2023 with the intent to create a safe, equitable, and regulated marketplace. The framework was ambitious. It called for a detailed licensing process, oversight by a newly formed Office of Cannabis Management, and careful planning to avoid the pitfalls other states had experienced in their early rollouts. What sounded promising on paper has proven to be far more complex in practice. The OCM has spent the past two years building the infrastructure to support a statewide cannabis market from scratch. That includes drafting rules, developing the licensing lottery, hiring staff, and setting up systems for product tracking, compliance, and equity-centered access. The result is a launch that is methodical but slow. Although the first retail licenses were awarded earlier this year, many license holders are still waiting for zoning approval, inspections, and final go-ahead from local governments. Businesses that are ready to open their doors are stalled in limbo as the state works through the layers of regulation that accompany a legal cannabis market. For consumers, the delays feel increasingly disconnected from the original promise. The law has passed. The infrastructure is forming. But the stores? Still out of reach. Albert Lea and the “First Store” Buzz Among the many towns preparing for Minnesota’s recreational cannabis debut, Albert Lea has unexpectedly taken center stage. A small city near the Iowa border, it is now home to what may become the first nontribal cannabis retailer in the state. The store, called The Smoking Tree, has already cleared local inspections and received strong support from city officials. It is fully built out, staff have been hired, and the location is ready to serve customers. The only thing missing is the final retail license from the Office of Cannabis Management. Despite its readiness, The Smoking Tree is still in a holding pattern. There is no confirmed date for when the OCM will issue its retail approvals, and the business, like many others, is caught between preparation and policy. While the symbolic significance of opening the first store is clear, it also underscores the deeper issue. The process, even for those ready to go, remains uncertain. For now, Albert Lea represents both hope and hesitation. It is a signal that recreational retail is on the horizon, but also a reminder of how far the system still has to go. Tribal Retail Already Up and Running While the state-managed dispensary system inches forward, several of Minnesota’s tribal nations have moved well ahead. Thanks to tribal sovereignty, Native nations are not bound by the same state licensing timeline. As a result, places like Red Lake, White Earth, and Prairie Island have been operating recreational cannabis stores for months. These tribal dispensaries have become essential access points for Minnesotans looking for legal cannabis without waiting for the state’s system to catch up. Many are well-stocked, professionally run, and open to the public. Customers from across the state have made the drive, turning tribal retailers into early leaders in Minnesota’s legal cannabis landscape. Still, access is limited by geography. Most of the tribal dispensaries are located in rural areas, hours away from major metro populations like Minneapolis and St. Paul. For many Minnesotans, especially those without the ability to travel long distances, these stores are not a realistic option for regular access. The tribal programs have shown what an operational cannabis market can look like in Minnesota. They offer a glimpse of what is possible when regulation meets execution. But for statewide availability, a larger and more accessible network is still needed. The Bigger Problem: No Product Supply Even when state-licensed dispensaries finally begin to open, another issue looms: there may be little to put on the shelves. Minnesota’s cannabis law allows for in-state cultivation, but the infrastructure to grow, process, and distribute cannabis at scale is not fully in place. That means the first wave of dispensaries could be met with a shortage of fresh, legal product. Much of the flower that was grown in the early excitement following legalization is now aging to the point of no return. Some of it was cultivated in anticipation of a faster rollout. But cannabis is not a shelf-stable product. Over time, it loses potency, terpenes fade, and the overall experience declines. Dispensaries may technically have product to sell, but the quality could fall far below consumer expectations. On top of that, new cultivators face a long runway. Building compliant grow operations, securing permits, hiring staff, and completing full grow cycles all take time. Many of these businesses are still waiting for final approval to begin operations. Realistically, it could be well into 2026 before Minnesota sees a consistent flow of high-quality, locally grown cannabis available for retail. For a state that has already waited nearly two years for dispensaries to open, the added wait for quality product will test the patience of even the most committed consumers. What Minnesotans Are Doing Instead With no recreational dispensaries open and no fresh product in sight, Minnesotans have started looking elsewhere. And for many, the answer has come not from marijuana, but from hemp. Hemp-derived Delta 9 THC products offer a legal, accessible alternative that delivers a familiar experience. Made from federally legal hemp and compliant with the 2018 Farm Bill, these products can be sold both online and in physical stores throughout the state. As long as the Delta 9 content remains under 0.3 percent by dry weight, they are fully legal at the federal and state level. The result is a growing market of gummies , topicals , flower , vapes , and beverages  that feel indistinguishable from traditional cannabis products. And unlike the still-pending dispensary model, these hemp-based options are already on shelves. Consumers can walk into certain shops, make a purchase, and enjoy their product the same day without having to wait for state approvals. For many, the convenience and reliability are reason enough. But there is also trust. Established retailers like Simply Crafted  have built a reputation for quality, transparency, and compliance. Lab-tested products, clear labeling, and helpful staff have made them a reliable choice for consumers who want consistency without the uncertainty of a developing state system. While the dispensary model continues to evolve, Minnesotans are not standing still. They are finding legal options that already work and embracing hemp-derived THC as a legitimate part of their cannabis experience. Looking Ahead — Dispensaries Will Come, But Not Soon There is no doubt that Minnesota’s adult-use cannabis market will eventually take shape. The infrastructure is being built. The licensing framework is active. The demand is already proven. But even with these elements in motion, a fully functioning dispensary system is still far from reality. Zoning challenges, regulatory bottlenecks, and delayed cultivation timelines all contribute to a launch that is moving in pieces rather than waves. Some towns have embraced the idea of retail cannabis, while others are slow to approve storefronts or outright restrict them. Meanwhile, growers are working to meet compliance standards before they can bring their product to market. For the average consumer, the wait is ongoing and without clear answers. Even when the first stores do open, early visitors may find limited selection, aging products, or understocked shelves. A smooth rollout requires more than just licenses; it requires coordination between cultivation, testing, retail, and logistics. That kind of supply chain takes time to build. Minnesota is on its way. But consumers hoping for a robust, well-stocked cannabis experience soon may be left waiting longer than expected. A Cannabis Market in Progress, an Alternative in Place Minnesota’s path to a fully operational recreational cannabis market is unfolding, but slowly. The first state-licensed dispensary may open soon. Others will follow. Yet the rollout has already made one thing clear: access does not come quickly, and quality does not arrive overnight. For consumers, the question is not just when dispensaries will open, but whether those early shelves will meet expectations. In the meantime, legal hemp-derived THC offers a reliable and immediate path forward. It is accessible, consistent, and already improving the cannabis experience for thousands across the state. Simply Crafted  is part of that solution. Based in Minnesota, the brand offers lab-tested Delta 9 flower , edibles , and more — all compliant with federal and state law. Available both in store and online, it gives Minnesotans an option that doesn’t require waiting for the system to catch up. The dispensaries will come. But no one has to wait to enjoy cannabis legally, safely, and confidently with Simply Crafted .

You’re packing your bags, checking your flight status, and mentally preparing for airport security. Then you pause — can you bring that Delta-9 THC gummy in your carry-on? It’s a question more travelers are asking as hemp-derived THC products become a go-to for calming pre-flight nerves, easing travel anxiety, or simply getting better sleep on the road. With options like low-dose gummies and discreet mints, the cannabis experience has never been more portable — or more legal. But legality doesn't always mean simplicity. Traveling with THC, even if it’s hemp-derived and Farm Bill compliant, comes with some gray areas. Between airport rules, state-by-state laws, and federal loopholes, there’s a lot to navigate. That’s where this guide comes in. Whether you’re road-tripping across state lines or catching a domestic flight, here’s what you need to know about traveling with hemp-derived Delta-9 — and how to do it the smart, legal way. Hemp-Derived THC 101 (And Why It’s Legal) Delta-9 THC is the compound most commonly associated with cannabis — it’s what produces the classic euphoric high. But what many people don’t realize is that not all Delta-9 is created — or regulated — the same. The key difference lies in the source. Hemp-derived Delta-9 is extracted from federally legal hemp plants, not marijuana. Thanks to the 2018 Farm Bill, any cannabinoid product derived from hemp (defined as cannabis with less than 0.3% Delta-9 THC by dry weight) is legal at the federal level. That means edibles, tinctures, and even beverages that contain Delta-9 THC, as long as they meet that weight-based threshold, are allowed in most U.S. states. What’s especially important is that hemp-derived Delta-9 is chemically identical to the Delta-9 THC found in dispensary products. The difference isn’t in the molecule — it’s in the legal classification of the source plant. Simply Crafted’s Delta-9 products are all made from hemp, fully compliant with federal law, and third-party lab tested. This means they can be shipped across state lines and — in many cases — taken with you when you travel. But that legality comes with nuance, and knowing the rules can make all the difference between a smooth trip and unnecessary stress. Can You Legally Travel With It? Traveling with hemp-derived Delta-9 THC isn’t always straightforward. While these products are federally legal, travel regulations — especially at airports and across state borders — can get complicated. Here’s what you need to know before you take off. Domestic Air Travel (TSA + FAA) The TSA isn’t actively searching for cannabis products. According to their own policy, they’re focused on security threats, not gummies. That said, all substances must be federally legal to fly with, and that includes hemp-derived THC. If your edible is under 0.3% Delta-9 THC by dry weight, it’s technically allowed. However, TSA agents have the right to flag anything they’re unsure about. In that case, it may be passed on to local law enforcement, whose response depends on state law. To reduce your risk: Keep products in original packaging with visible THC content. Carry a printed or digital Certificate of Analysis (COA) from the manufacturer. Stick to edibles or tinctures — flower or vapes may raise more questions. Road Trips + State Laws Driving between states? You’ll need to know the laws in both your origin and your destination. While hemp-derived THC is legal federally, some states still ban or heavily restrict it — even if it's compliant. A few states to be cautious about: Idaho Kansas South Carolina (grey area) Utah (restricted cannabinoids) Even in legal states, consuming THC while driving or having open containers in the vehicle can result in DUI charges or other legal trouble. Treat hemp-derived THC products like alcohol — keep them sealed and out of reach while on the road. International Travel Don’t do it. Period. Even if the product is hemp-derived and legal in the U.S., international laws do not recognize the same distinction. Many countries still classify THC, regardless of source, as an illegal substance. Being caught with it abroad can lead to fines, detainment, or worse. If you’re crossing a national border, leave your hemp-derived THC products at home. Travel-Friendly Products to Consider Not all D9 THC products are created for life on the go. When traveling, discretion, convenience, and compliance matter more than ever. That’s why hemp-derived Delta-9 in edible form is quickly becoming a favorite among travelers. Delta-9 THC gummies are a standout option. They’re compact, odorless, and easy to dose. Whether you need a little help relaxing before a flight or want to unwind at the end of a long day on the road, a precisely dosed gummy offers a reliable experience without drawing attention. Tinctures are another travel-friendly choice. They’re low-profile, often resemble standard wellness supplements, and can be taken sublingually or added to drinks. Ideal for those who want control over their dosage and onset time. Then there are mints — ultra discreet, pocket-sized, and perfect for microdosing. With no smell and a familiar form, they’re one of the easiest ways to carry Delta-9 without any stress. Simply Crafted offers a variety of low-dose, hemp-derived Delta-9 products that check every box for travel: legal, lab-tested, and designed for real-life use. Whether you're heading out for a weekend road trip or a cross-country flight, these options deliver calm, clarity, and comfort—no matter where you land. Final Thoughts: Travel Legal, Feel Good More travelers are turning to hemp-derived Delta-9  for a reason. It’s legal, low-key, and delivers the same calming effects as traditional cannabis — perfect for easing airport stress, long drives, or winding down after a day of exploring. When sourced from compliant, transparent brands, it’s one of the smartest ways to bring a bit of relief on the road. Simply Crafted makes travel-ready Delta-9 THC  easy. From discreet gummies to microdosed mints, each product is designed with your journey in mind — compact, compliant, and lab-tested for peace of mind wherever you go. Ready to pack something that actually makes travel better? Browse Simply Crafted’s extensive menu of potent hemp-derived D9 THC products. Travel smart. Feel good. And keep it simple with Simply Crafted .

The winds of change are sweeping across the United States as the Drug Enforcement Administration (DEA) signals a landmark shift in its stance on cannabis. What once loomed over the industry as a formidable barrier might soon be reclassified, moving cannabis from the strict confines of Schedule I to the more permissive realm of Schedule III. This potential reclassification is not just a procedural change; it's a beacon of progress for both the cannabis industry and its supporters nationwide. As we delve into the implications of this monumental shift, understand how it could liberate the industry from longstanding legal shackles, inspire innovation, and expand medical research opportunities. Join us in dissecting this historic moment, poised to redefine the landscape of cannabis in America. Understanding Drug Schedules - Schedule I Explained In the realm of controlled substances, Schedule I represents the strictest classification under the Controlled Substances Act (CSA). This category is reserved for drugs that the federal government considers to have "no currently accepted medical use and a high potential for abuse." Substances like heroin, LSD, and until now, cannabis, share this designation, underscoring a perceived lack of therapeutic value and significant risk. The implications are severe: stringent legal penalties, significant hurdles for research, and a robust stigma around their use. The classification of cannabis as a Schedule I drug has long been a contentious issue, given the growing body of research and state-level legalization movements that suggest its potential medical benefits and relative safety compared to other substances in the same category. Ultimately, critics argue that this harsh classification of cannabis has hindered comprehensive scientific study and delayed therapeutic innovations that could benefit millions throughout the nation. The New Classification - Schedule III Unpacked A shift to Schedule III marks a significant moderation in the DEA's view of cannabis. Drugs classified under Schedule III are recognized to have a lower potential for abuse compared to those in Schedule I and II and are considered to have currently accepted medical uses. This category includes substances such as anabolic steroids, testosterone, and ketamine, which are permitted for medical treatment and subject to less stringent regulatory oversight. The reclassification to Schedule III for cannabis would not only facilitate greater research opportunities by easing some of the federal restrictions that have historically limited scientific studies but also promotes a more regulated yet accessible market. Furthermore, it allows for more straightforward prescription processes in medical contexts, enhancing patient access and compliance. This shift is poised to expand the medical cannabis industry significantly, broadening the scope of potential medical applications and making these treatments more accessible to patients across the nation. This reclassification could significantly alter the landscape of cannabis research and medical use, potentially leading to new discoveries and therapies that were previously hindered by restrictive laws. Why the Change Matters The reclassification of cannabis from a Schedule I to a Schedule III drug represents a monumental shift in how the United States government perceives and manages this substance. This change reflects an evolving understanding of cannabis and its potential benefits, driven by years of research and public advocacy. By lowering the scheduling status, the federal government acknowledges the therapeutic potential and decreased risk associated with cannabis use, which aligns more closely with the current scientific and medical consensus. This reclassification could dramatically reduce the stigma associated with cannabis use, both recreationally and medicinally. It opens the door for more robust and federally supported research initiatives, which can explore the full spectrum of cannabis' therapeutic benefits without the previous legal and bureaucratic constraints. For patients, this means improved access to cannabis-based treatments that are regulated for quality and efficacy. Additionally, the change could spur significant legal reforms across states, aligning state and federal laws, and reducing the legal uncertainties businesses and consumers currently face. By reducing the barriers to research and legal use, this shift also paves the way for significant economic growth within the cannabis industry. Businesses can operate more freely, access banking services and insurance, and invest more confidently in their operations and product development. Reclassification could lead to innovations in product offerings, improvements in product safety, and more effective medicinal applications of cannabis. Impact on the Cannabis Industry and Users The potential reclassification of cannabis to Schedule III opens up a plethora of opportunities for the cannabis industry and significantly enhances the experience of both recreational and medical users. For the industry, this change means a potential reduction in legal barriers, which have previously constrained everything from production and distribution to marketing and sales. Businesses can expect reduced regulatory costs and complexities, making it easier to operate profitably while expanding into new markets. For investors, the reduced risk and increased legitimacy of the industry could lead to a surge in capital inflow. This financial boost is likely to drive innovation in cultivation techniques, product quality, and diversity of product offerings. As the industry grows, consumers will benefit from higher-quality products, more competitive pricing, and greater access to a variety of cannabis-based products. On the medical front, patients who rely on cannabis for therapeutic purposes will find it easier to obtain prescriptions and access consistent, quality-controlled cannabis treatments. Physicians may also feel more comfortable prescribing cannabis treatments, knowing that its reclassification acknowledges its medical value and reduces potential legal ramifications. Recreational users will benefit from an industry that can operate more openly and transparently, ensuring safer and more reliable products. Additionally, the normalization and destigmatization of cannabis use could foster a more inclusive community of users, promoting responsible use and knowledge sharing about the benefits and risks of cannabis. Embrace the Future with Simply Crafted As the DEA inches closer to potentially reclassifying cannabis as a Schedule III drug, we stand on the brink of a new era for cannabis in America. This shift could redefine the cultural and economic landscape of cannabis, offering new opportunities for growth, innovation, and acceptance. It signifies a move towards a more rational, science-based approach that recognizes the substantial benefits of cannabis while addressing the nation's need for effective regulation. At Simply Crafted, we are excited about what the future holds and remain committed to providing our customers with the highest quality CBD, Delta-9 THC, Delta-8 THC, and cannabis seeds. Whether you are a medical patient seeking relief or a recreational user exploring the benefits of cannabis, Simply Crafted offers a trusted, legal source for all your cannabis needs. Discover the possibilities with Simply Crafted. Visit us today to explore our extensive range of products, tailored to offer you the best in quality and price, no matter where you are in Minnesota or across the nation. Embrace the change with us, and be part of the growing community that values quality, transparency, and innovation in cannabis.